Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.


Journal

Pharmacological reviews
ISSN: 1521-0081
Titre abrégé: Pharmacol Rev
Pays: United States
ID NLM: 0421737

Informations de publication

Date de publication:
01 2023
Historique:
received: 09 08 2020
accepted: 27 09 2022
entrez: 9 2 2023
pubmed: 10 2 2023
medline: 14 2 2023
Statut: ppublish

Résumé

G protein-coupled receptors (GPCRs) are known to interact with several other classes of integral membrane proteins that modulate their biology and pharmacology. However, the extent of these interactions and the mechanisms of their effects are not well understood. For example, one class of GPCR-interacting proteins, receptor activity-modifying proteins (RAMPs), comprise three related and ubiquitously expressed single-transmembrane span proteins. The RAMP family was discovered more than two decades ago, and since then GPCR-RAMP interactions and their functional consequences on receptor trafficking and ligand selectivity have been documented for several secretin (class B) GPCRs, most notably the calcitonin receptor-like receptor. Recent bioinformatics and multiplexed experimental studies suggest that GPCR-RAMP interactions might be much more widespread than previously anticipated. Recently, cryo-electron microscopy has provided high-resolution structures of GPCR-RAMP-ligand complexes, and drugs have been developed that target GPCR-RAMP complexes. In this review, we provide a summary of recent advances in techniques that allow the discovery of GPCR-RAMP interactions and their functional consequences and highlight prospects for future advances. We also provide an up-to-date list of reported GPCR-RAMP interactions based on a review of the current literature. SIGNIFICANCE STATEMENT: Receptor activity-modifying proteins (RAMPs) have emerged as modulators of many aspects of G protein-coupled receptor (GPCR)biology and pharmacology. The application of new methodologies to study membrane protein-protein interactions suggests that RAMPs interact with many more GPCRs than had been previously known. These findings, especially when combined with structural studies of membrane protein complexes, have significant implications for advancing GPCR-targeted drug discovery and the understanding of GPCR pharmacology, biology, and regulation.

Identifiants

pubmed: 36757898
pii: pharmrev.120.000180
doi: 10.1124/pharmrev.120.000180
pmc: PMC9832379
doi:

Substances chimiques

Receptor Activity-Modifying Proteins 0
Ligands 0
Receptors, G-Protein-Coupled 0
Membrane Proteins 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-34

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM136640
Pays : United States

Informations de copyright

Copyright © 2023 by The Author(s).

Références

Biochem Biophys Res Commun. 2016 Feb 19;470(4):894-9
pubmed: 26820533
Front Pharmacol. 2021 Oct 12;12:748993
pubmed: 34712139
Front Pharmacol. 2022 Mar 07;13:832589
pubmed: 35341216
Nature. 2018 Sep;561(7724):492-497
pubmed: 30209400
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24093-24099
pubmed: 31712427
J Med Chem. 2020 Jul 23;63(14):7906-7920
pubmed: 32558564
Biochim Biophys Acta. 2007 Aug;1770(8):1145-50
pubmed: 17493758
J Mol Neurosci. 2005;26(2-3):265-76
pubmed: 16012200
Crit Rev Biochem Mol Biol. 2016;51(1):65-71
pubmed: 26740457
Regul Pept. 2008 Jan 10;145(1-3):65-71
pubmed: 17884192
Front Mol Biosci. 2021 Aug 26;8:720561
pubmed: 34513925
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20244-9
pubmed: 18077336
Mol Neurobiol. 2021 Oct;58(10):5369-5382
pubmed: 34312771
Science. 2021 Apr 9;372(6538):
pubmed: 33602864
J Pharmacol Exp Ther. 2020 May;373(2):269-278
pubmed: 32071103
Mol Metab. 2021 Nov;53:101296
pubmed: 34271220
Front Endocrinol (Lausanne). 2022 Jan 12;12:807882
pubmed: 35095771
Biochem Biophys Res Commun. 2012 Feb 24;418(4):824-9
pubmed: 22321396
Trends Pharmacol Sci. 2021 Mar;42(3):135-150
pubmed: 33358695
Science. 2019 Apr 12;364(6436):148-153
pubmed: 30975883
Gene. 2020 Oct 5;757:144949
pubmed: 32679290
Front Oncol. 2021 May 19;11:671418
pubmed: 34094972
Mol Cell. 2015 Jun 18;58(6):1040-52
pubmed: 25982113
ACS Chem Biol. 2015 Aug 21;10(8):1797-804
pubmed: 26006698
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Pharmacol Exp Ther. 2021 Jun;377(3):417-440
pubmed: 33727283
Cell Discov. 2016 May 17;2:16012
pubmed: 27462459
Protein Cell. 2016 May;7(5):325-37
pubmed: 27085723
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3684-9
pubmed: 10725388
J Surg Res. 2017 Nov;219:50-60
pubmed: 29078910
Nat Rev Mol Cell Biol. 2002 Sep;3(9):639-50
pubmed: 12209124
Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R467-78
pubmed: 16195494
Expert Rev Neurother. 2022 Mar;22(3):221-230
pubmed: 35240905
Biochem Pharmacol. 2003 Dec 1;66(11):2107-15
pubmed: 14609735
J Biol Chem. 2009 Aug 21;284(34):22641-8
pubmed: 19535343
Nat Methods. 2006 Dec;3(12):995-1000
pubmed: 17072308
Nature. 1998 May 28;393(6683):333-9
pubmed: 9620797
Exp Cell Res. 2022 Jul 15;416(2):113139
pubmed: 35390315
Elife. 2017 Jun 29;6:
pubmed: 28661401
Cell Commun Signal. 2022 Apr 12;20(1):52
pubmed: 35413847
J Pharmacol Toxicol Methods. 1999 Dec;42(4):217-24
pubmed: 11033437
Protein Sci. 2012 Feb;21(2):199-210
pubmed: 22102369
J Biol Chem. 2017 Apr 28;292(17):7131-7144
pubmed: 28283573
Expert Opin Ther Targets. 2020 Feb;24(2):91-100
pubmed: 32003253
PLoS One. 2019 May 31;14(5):e0216996
pubmed: 31150417
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):151-6
pubmed: 9874787
J Biol Chem. 2000 Oct 6;275(40):31438-43
pubmed: 10903324
Commun Biol. 2021 Jun 23;4(1):776
pubmed: 34163006
Nat Commun. 2018 Dec 6;9(1):5224
pubmed: 30523250
Br J Pharmacol. 2012 May;166(1):110-20
pubmed: 21658025
Neuroscience. 2020 Nov 1;447:74-93
pubmed: 31881259
Nat Methods. 2015 Jul;12(7):661-663
pubmed: 26030448
Sci Adv. 2021 Nov 12;7(46):eabj7917
pubmed: 34757789
ACS Pharmacol Transl Sci. 2020 Mar 20;3(2):263-284
pubmed: 32296767
Acta Pharm Sin B. 2022 Feb;12(2):637-650
pubmed: 35256936
Nature. 2017 Jun 1;546(7656):118-123
pubmed: 28437792
Biomolecules. 2022 Sep 11;12(9):
pubmed: 36139120
Trends Neurosci. 2008 Feb;31(2):74-81
pubmed: 18199492
Lancet. 2018 Nov 24;392(10161):2280-2287
pubmed: 30360965
Diabetes. 2018 May;67(5):805-817
pubmed: 29467172
Onco Targets Ther. 2020 Apr 20;13:3291-3301
pubmed: 32368088
Diabetes. 2011 Apr;60(4):1063-71
pubmed: 21357463
Endocrinology. 2014 Jan;155(1):21-6
pubmed: 24169554
ACS Pharmacol Transl Sci. 2020 Jun 25;3(4):706-719
pubmed: 32832872
Sci Rep. 2017 Sep 28;7(1):12389
pubmed: 28959041
Adv Sci (Weinh). 2022 Oct;9(30):e2202620
pubmed: 36047655
Biochem Pharmacol. 2018 Jul;153:299-309
pubmed: 29530506
Semin Cell Dev Biol. 2004 Jun;15(3):299-308
pubmed: 15125893
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
Adv Exp Med Biol. 2012;744:87-103
pubmed: 22434110
Endocrinology. 2017 Aug 1;158(8):2680-2693
pubmed: 28586439
iScience. 2019 Jan 25;11:366-374
pubmed: 30660104
Nat Rev Drug Discov. 2017 Sep;16(9):787-810
pubmed: 28706220
Biochemistry. 2007 Jun 12;46(23):7022-33
pubmed: 17503773
Structure. 2010 Sep 8;18(9):1083-93
pubmed: 20826335
Adv Pharmacol. 2011;62:349-80
pubmed: 21907915
J Biol Chem. 2003 May 30;278(22):20196-202
pubmed: 12646556
Pharmacol Rev. 2015 Jul;67(3):564-600
pubmed: 26071095
Sci Rep. 2017 Jun 9;7(1):3187
pubmed: 28600500
J Biol Chem. 2008 Jan 18;283(3):1525-1533
pubmed: 17993461
Trends Biochem Sci. 2006 Nov;31(11):631-8
pubmed: 17010614
PLoS One. 2014 Jul 10;9(7):e102356
pubmed: 25010197
J Cell Sci. 2005 Oct 15;118(Pt 20):4709-20
pubmed: 16188935
J Biol Chem. 2018 Jun 15;293(24):9370-9387
pubmed: 29717000
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2122037119
pubmed: 35914163
Sci Rep. 2018 Mar 29;8(1):5400
pubmed: 29599435
Clin Ther. 2005 Oct;27(10):1500-12
pubmed: 16330288
Br J Pharmacol. 2022 Jul;179(14):3651-3674
pubmed: 35106752
Endocrinology. 2008 Nov;149(11):5423-31
pubmed: 18599553
J Biol Chem. 2011 Sep 16;286(37):32188-97
pubmed: 21730065
Biophys Chem. 2020 Dec;267:106477
pubmed: 33137565
Exp Hematol. 2021 Jul;99:1-11
pubmed: 34029637
Br J Pharmacol. 2013 Feb;168(4):822-34
pubmed: 22946657
Br J Pharmacol. 2022 Feb;179(3):416-434
pubmed: 34289083
Biochemistry. 2018 Aug 14;57(32):4915-4922
pubmed: 30004692
J Biol Chem. 2018 Oct 12;293(41):15840-15854
pubmed: 30139742
Trends Pharmacol Sci. 2020 Apr;41(4):249-265
pubmed: 32115276
Evol Bioinform Online. 2008 Apr 28;4:153-69
pubmed: 19204815
Peptides. 2018 Dec;110:10-18
pubmed: 30385288
J Biol Chem. 2005 Jun 24;280(25):23926-35
pubmed: 15805108
Mol Cell. 2020 Feb 6;77(3):656-668.e5
pubmed: 32004469
Genet Med. 2019 Oct;21(10):2345-2354
pubmed: 31000793
J Biol Chem. 2019 Jul 19;294(29):11062-11086
pubmed: 31171722
Front Physiol. 2022 Mar 29;13:840763
pubmed: 35422711
J Biol Chem. 2007 Jun 22;282(25):18094-18099
pubmed: 17470425
J Biol Chem. 2005 Mar 11;280(10):9297-307
pubmed: 15613468
Adv Pharmacol. 2020;88:115-141
pubmed: 32416865
ACS Chem Neurosci. 2022 Mar 16;13(6):751-765
pubmed: 35245037
Front Physiol. 2022 Feb 25;13:833645
pubmed: 35283798
Sci Rep. 2019 Jul 29;9(1):10942
pubmed: 31358858
Br J Pharmacol. 2018 Jan;175(1):3-17
pubmed: 29059473
Physiol Rev. 2014 Oct;94(4):1099-142
pubmed: 25287861
Biomedicines. 2022 Feb 24;10(3):
pubmed: 35327335
Nat Commun. 2020 Mar 9;11(1):1272
pubmed: 32152292
J Biol Chem. 2003 Jan 31;278(5):3293-7
pubmed: 12446722
J Med Chem. 2021 Aug 12;64(15):11183-11194
pubmed: 34288673
Oncol Lett. 2021 Jan;21(1):60
pubmed: 33281971
J Pept Sci. 2015 Dec;21(12):905-12
pubmed: 26767744
Mol Pharmacol. 2005 May;67(5):1655-65
pubmed: 15692146
ACS Pharmacol Transl Sci. 2020 Mar 12;3(2):305-320
pubmed: 32296770
Annu Rev Pharmacol Toxicol. 2016;56:469-87
pubmed: 26514202
Int J Mol Sci. 2014 Jan 16;15(1):1112-42
pubmed: 24441568
C R Biol. 2005 Aug;328(8):691-700
pubmed: 16125647
Front Neurol. 2022 Aug 05;13:947524
pubmed: 35989941
Curr Protoc Cell Biol. 2020 Mar;86(1):e100
pubmed: 31876395
Peptides. 2010 Jul;31(7):1400-4
pubmed: 20347903
Cell Rep. 2020 Feb 11;30(6):1714-1723.e6
pubmed: 32049005
ACS Med Chem Lett. 2010 Jan 12;1(1):24-9
pubmed: 24900170
PLoS One. 2017 Jun 6;12(6):e0179067
pubmed: 28586385
J Cell Sci. 2002 Feb 1;115(Pt 3):455-65
pubmed: 11861753
Front Cell Dev Biol. 2021 Feb 12;9:635307
pubmed: 33644072
J Biol Chem. 2001 Nov 9;276(45):42182-90
pubmed: 11535606
Blood. 2009 Jun 11;113(24):6085-93
pubmed: 19380869
J Biol Chem. 2016 Apr 15;291(16):8686-700
pubmed: 26895962
FEBS J. 2022 Dec;289(24):7670-7687
pubmed: 34741587
Expert Opin Drug Discov. 2022 Aug;17(8):839-848
pubmed: 35733389
J Biol Chem. 2016 Jan 29;291(5):2345-56
pubmed: 26644465
Curr Protoc Pharmacol. 2016 Dec 13;75:2.16.1-2.16.31
pubmed: 27960030
Nature. 2018 Jan 3;553(7686):106-110
pubmed: 29300013
Pharmacol Ther. 2006 Jan;109(1-2):173-97
pubmed: 16111761
Nucleic Acids Res. 2008 Jan;36(Database issue):D735-40
pubmed: 18056084
Biology (Basel). 2022 May 21;11(5):
pubmed: 35625516
ACS Pharmacol Transl Sci. 2018 Apr 23;1(1):32-49
pubmed: 32219203
J Mol Cell Cardiol. 2012 Jan;52(1):165-74
pubmed: 22100352
Protein Eng. 1994 Feb;7(2):195-203
pubmed: 8170923
Gen Comp Endocrinol. 2022 Nov 01;328:114123
pubmed: 36075341
PLoS One. 2013 Oct 02;8(10):e76366
pubmed: 24098485
J Biol Chem. 2009 Jan 2;284(1):610-618
pubmed: 18981183
J Am Chem Soc. 2012 Jul 4;134(26):10959-65
pubmed: 22679925
Lancet. 2021 Dec 11;398(10317):2160-2172
pubmed: 34798060
Mol Pharmacol. 2018 Apr;93(4):355-367
pubmed: 29363552
Brain Behav Immun Health. 2021 Oct 05;18:100361
pubmed: 34746878
BMC Mol Biol. 2005 Mar 24;6:7
pubmed: 15790393
Adv Exp Med Biol. 2012;744:25-37
pubmed: 22434105
Front Endocrinol (Lausanne). 2022 Jun 29;13:906586
pubmed: 35846294
Headache. 2018 Nov;58 Suppl 3:238-275
pubmed: 30242830
J Biol Chem. 2015 Sep 18;290(38):23009-22
pubmed: 26198634
Int J Mol Sci. 2019 Jan 24;20(3):
pubmed: 30682804
J Biol Chem. 2006 Mar 17;281(11):7205-13
pubmed: 16410241
Front Pharmacol. 2019 Feb 19;10:125
pubmed: 30837883
Nat Commun. 2021 Jan 18;12(1):422
pubmed: 33462236
Biochemistry. 2009 Dec 15;48(49):11773-85
pubmed: 19886671
Nat Genet. 2022 Feb;54(2):152-160
pubmed: 35115687
Mol Pharmacol. 2006 Jun;69(6):1984-9
pubmed: 16531504
Hypertension. 2013 Feb;61(2):341-51
pubmed: 23297372
Biochemistry. 2002 Sep 24;41(38):11398-404
pubmed: 12234182
Biochem Pharmacol. 2017 Oct 15;142:96-110
pubmed: 28705698
J Mol Cell Cardiol. 2014 Dec;77:73-85
pubmed: 25264174
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16702-7
pubmed: 17923674
Nature. 2016 Dec 1;540(7631):60-68
pubmed: 27905440
Mol Pharmacol. 2003 Jun;63(6):1256-72
pubmed: 12761335
Nature. 2017 Jun 8;546(7657):248-253
pubmed: 28538729
ACS Pharmacol Transl Sci. 2020 Feb 26;3(2):246-262
pubmed: 32296766
Bioorg Med Chem Lett. 2013 Jun 1;23(11):3157-61
pubmed: 23632269
Mol Pharmacol. 2008 Oct;74(4):1059-71
pubmed: 18593822
J Clin Endocrinol Metab. 2008 Dec;93(12):4948-54
pubmed: 18840636
ACS Pharmacol Transl Sci. 2020 Feb 26;3(2):296-304
pubmed: 32296769
Trends Pharmacol Sci. 2022 Apr;43(4):321-334
pubmed: 35078643
Molecules. 2019 Feb 01;24(3):
pubmed: 30717191
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
Mol Pharmacol. 2006 Nov;70(5):1750-60
pubmed: 16912219
Mol Pharmacol. 1999 Jul;56(1):235-42
pubmed: 10385705
J Mol Graph Model. 2022 Nov;116:108254
pubmed: 35803082
J Mol Endocrinol. 2013 Jul 03;51(1):191-202
pubmed: 23674134
Pharmacol Res Perspect. 2020 Jun;8(3):e00595
pubmed: 32529807
J Biol Chem. 2000 Sep 22;275(38):29602-9
pubmed: 10882736
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
PLoS One. 2014 Jan 13;9(1):e85237
pubmed: 24454825
Nature. 2017 Jun 8;546(7657):254-258
pubmed: 28562585
Front Bioeng Biotechnol. 2019 Mar 26;7:56
pubmed: 30972335
Biochim Biophys Acta Biomembr. 2020 Mar 1;1862(3):183174
pubmed: 31887275
Cephalalgia. 2011 Apr;31(6):712-22
pubmed: 21383045
Diabet Med. 2004 Nov;21(11):1204-12
pubmed: 15498087
Cell Res. 2020 Dec;30(12):1098-1108
pubmed: 33239759
Gene X. 2019 Feb 14;2:100009
pubmed: 32550545
Drug Discov Today. 2009 Apr;14(7-8):413-9
pubmed: 19150656
Biomedicines. 2021 Aug 23;9(8):
pubmed: 34440272
Biochim Biophys Acta Biomembr. 2019 May 1;1861(5):997-1003
pubmed: 30826286
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Protein Sci. 2008 Nov;17(11):1907-14
pubmed: 18725456
FASEB J. 2014 Mar;28(3):1237-47
pubmed: 24308973
Circ Res. 2006 Feb 3;98(2):262-70
pubmed: 16373602
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12309-12314
pubmed: 29087309
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24
pubmed: 12370423
ACS Pharmacol Transl Sci. 2021 Mar 22;4(2):813-823
pubmed: 33860204
J Biol Chem. 2007 Apr 20;282(16):12260-71
pubmed: 17310067
FEBS J. 2023 Jan;290(1):196-208
pubmed: 35942636
ACS Pharmacol Transl Sci. 2020 Jul 24;3(4):759-772
pubmed: 32832875
Calcif Tissue Int. 2005 Aug;77(2):96-103
pubmed: 16075364
Br J Pharmacol. 2010 Mar;159(5):1059-68
pubmed: 20015292
Front Endocrinol (Lausanne). 2018 Nov 30;9:695
pubmed: 30555412
Sci Adv. 2019 Sep 18;5(9):eaaw2778
pubmed: 31555726
Science. 2022 Mar 25;375(6587):eabm9609
pubmed: 35324283
ACS Pharmacol Transl Sci. 2019 Mar 18;2(3):183-197
pubmed: 32219220
J Biol Chem. 2016 Oct 14;291(42):21925-21944
pubmed: 27566546
Int J Mol Sci. 2014 May 14;15(5):8570-90
pubmed: 24830558
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Nature. 2021 Jun;594(7864):589-593
pubmed: 34135509
J Bone Miner Res. 2012 Aug;27(8):1821-9
pubmed: 22437792
Peptides. 2017 Feb;88:1-7
pubmed: 27940069
PLoS One. 2021 Aug 26;16(8):e0256646
pubmed: 34437633
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12015-12020
pubmed: 29078385
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Trends Pharmacol Sci. 2008 Dec;29(12):633-9
pubmed: 18930324
Nat Rev Neurol. 2018 Jun;14(6):338-350
pubmed: 29691490
Mol Cell Endocrinol. 2000 Apr 25;162(1-2):35-43
pubmed: 10854696

Auteurs

Ilana B Kotliar (IB)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.).

Emily Lorenzen (E)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.).

Jochen M Schwenk (JM)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.).

Debbie L Hay (DL)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.).

Thomas P Sakmar (TP)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.) sakmar@rockefeller.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH